Pharmaceutical Industry Websites

The following sites are sponsored by the manufacturers of these pharmaceutical agents:

Treat to Target #3 – FRAX

February 9, 2018 @ 5:04 pm
posted by Dr Ginther

Our Target is NO NEW FRACTURES.  The original goal by DXA was a  T-score of -2.4 or better.  But age is a huge factor in actual fracture risk.  The fracture risk of a T-score of -2.5 at age 60 is the same as a T-score of -3.1 at age 50, is the same as a T-score of -1.3 at age 80.

FRAX was developed by WHO and the International Osteoporosis Foundation to take age and other factors into account.  The big 5 risk factors are age, previous fracture, parental hip fracture, smoking, and oral or inhaled corticosteroids.  Rheumatoid arthritis (or diabetes), over 3 doses of alcohol daily, and BMI < 19 or > 35 also count.  Male and Female are different.  Femoral Neck of the hip BMD by DXA is only 30% of the calculation when available.

Treat to Target by FRAX is a “Major Osteoporotic” (wrist, shoulder, hip or clinically noticed spine) Fracture Risk of < 20%.  Alternately a Hip Fracture Risk of < 3.0 is the target.  FRAX identifies a more individualized fracture risk than DXA with or without fragility fracture.

Look up the FRAX tool at http://www.sheffield.ac.uk/FRAX/

FRAX gives different targets than DXA because it takes additional risk factors into account.  And there have been some refinements added.

Jay Ginther, MD

Leave a Reply